Piramal Pharma Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.2%1-day move

₹147.80

prior close

₹148.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.2-0.3+0.2+2.1+3.9+10.9+11.8+11.5+24.5+19.0+10.3+21.3

Up moveDown movePending

AI summary

Piramal Pharma Limited has informed the exchanges about a scheduled earnings conference call on 29th April 2026 from 9:30 AM to 10:15 AM IST. The call will discuss the company's Q4 and Full-year FY2026 financial results. The company has provided multiple dial-in numbers for participants in India, USA, UK, Singapore, and Hong Kong, along with a registration link for express join. This is a routine regulatory disclosure under SEBI Listing Regulations, informing investors and analysts about the timing and access details for the earnings discussion.

Likely market impact

This is a standard informational filing that gives investors advance notice of when Q4/FY2026 earnings will be discussed. It does not contain any material corporate news or financial figures but allows shareholders and analysts to plan participation in the earnings call.